Skip to main content
Log in

Sequence variation analysis of the E2 gene of human papilloma virus type 16 in cervical lesions from women in Greece

  • Original Article
  • Published:
Archives of Virology Aims and scope Submit manuscript

Abstract

The E2 gene of human papilloma virus is expressed at the early stage of the viral life cycle, encoding the E2 transcription factor, and regulates the expression of E6 and E7 oncogenes. Disruption of E2 gene due to viral integration inhibits the transcriptional suppression of the HPV oncogenes, inducing cell proliferation. In the present study, a total of 22 HPV16-positive cytological specimens derived from high- and low-grade cervical intraepithelial lesions were investigated in order to identify sequence variations in the HPV16 E2 ORF. The E2 gene was amplified by PCR using external and internal overlapping sets of primers. Amplicons were cloned and sequenced. Disruption sites were detected in cervical samples diagnosed as high-grade cervical intraepithelial lesions. Moreover, sequence variations were identified in the E2 ORF and specific variations were associated with non-European variants such as African type I, African type II and Asian American. A total of three new sequence variations were identified at positions 2791, 2823 (transactivation domain) and 3361 (hinge region). Distinct phylogenetic branches were formed according to E2 analysis that characterized the different HPV16 variants. It was ascertained that non-European variants are circulating in the Greek population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401:70–79

    Article  PubMed  CAS  Google Scholar 

  2. Zur Hausen H (1996) Papillomavirus infections—a major cause of human cancers. Biochim Biophys Acta 1288:F55–F78

    PubMed  Google Scholar 

  3. Bernard HU, Calleja-Macias IE, Dunn ST (2006) Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer 118:1071–1076

    Article  PubMed  CAS  Google Scholar 

  4. Yamada T, Wheeler CM, Halpern AL, Stewart ACM, Hildesheim A, Jenison SA (1995) Human Papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2 and L1 coding segments. J Virol 69:7743–7753

    PubMed  CAS  Google Scholar 

  5. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Muñoz N (2008) Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26:K1–K17

    Article  PubMed  Google Scholar 

  6. Schiffman M, Clifford G, Buonaguro FM (2009) Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer 4:8

    Article  PubMed  Google Scholar 

  7. Sundström K, Eloranta S, Sparén P, Arnheim Dahlström L et al (2010) Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix. Cancer Epidemiol Biomarkers Prev 19:2469–2478

    Article  PubMed  Google Scholar 

  8. Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE (2010) Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Cancer Epidemiol Biomarkers Prev 19:1675–1681

    Article  PubMed  Google Scholar 

  9. Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S (2010) Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202:1789–1799

    Article  PubMed  Google Scholar 

  10. Dong SM, Kim HS, Rha SH, Sidransky D (2001) Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 7:1982–1986

    PubMed  CAS  Google Scholar 

  11. Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, Dem A, Dembele B, Critchlow CW, Xi L, Lu H, McIntosh MW, Young AM, Kiviat NB (2005) Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst 97:273–282

    Article  PubMed  CAS  Google Scholar 

  12. Smotkin D, Wettstein FO (1986) Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci USA 83:4680–4684

    Article  PubMed  CAS  Google Scholar 

  13. Soeda E, Ferran MC, Baker CC, McBride AA (2006) Repression of HPV16 early region transcription by the E2 protein. Virology 351:29–41

    Article  PubMed  CAS  Google Scholar 

  14. Longworth MS, Laimins LA (2004) Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 68:362–372

    Article  PubMed  CAS  Google Scholar 

  15. Hamid NA, Brown C, Gaston K (2009) The regulation of cell proliferation by the papillomavirus early proteins. Cell Mol Life Sci 66:1700–1717

    Article  PubMed  CAS  Google Scholar 

  16. Huang LW, Choa SL, Lee BH, Lee BH (2008) Integration of human papillomavirus type-16 and type-18 is a very early event in cervical carcinogenesis. J Clin Pathol 61:627–631

    Article  PubMed  Google Scholar 

  17. Cricca M, Morselli-Labate AM, Venturoli S et al (2007) Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions. Gynecol Oncol 106(549):557

    Google Scholar 

  18. Briolat J, Dalstein V, Saunier M et al (2007) HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int J Cancer 121:2198–2204

    Article  PubMed  CAS  Google Scholar 

  19. Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM (2006) Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 44:1755–1762

    Article  PubMed  CAS  Google Scholar 

  20. Li W, Wang W, Si M et al (2008) The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma. J Cancer Res Clin Oncol 134:1355–1361

    Article  PubMed  Google Scholar 

  21. Tonon SA, Picconi MA, Bos PD, Zinovich JB, Galuppo J, Alonio LV, Teyssie AR (2001) Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions. J Clin Virol 21:129–134

    Article  PubMed  CAS  Google Scholar 

  22. De Marco L, Gillio-Tos A, Bonello L, Ghisetti V, Ronco G, Merletti F (2007) Detection of human papillomavirus type 16 integration in preneoplastic cervical lesions and confirmation by DIPS-PCR and sequencing. J Clin Virol 38:7–13

    Article  PubMed  Google Scholar 

  23. Andersson S, Safari H, Mints M, Lewensohn-Fuchs I, Gyllensten U, Johansson B (2005) Type distribution, viral load and integration state of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br J Cancer 92:2195–2200

    Article  PubMed  CAS  Google Scholar 

  24. Hudelist G, Manavi M, Pischinger KID, Watkins-Riedel T, Singer CF, Kubista E, Czerwenka KF (2004) Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol Oncol 92:873–880

    Article  PubMed  CAS  Google Scholar 

  25. Pett MR, Herdman MT, Palmer RD, Yeo GSH, Shivji MK, Stanley MA, Coleman N (2006) Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc Natl Acad Sci USA 103:3822–3827

    Article  PubMed  CAS  Google Scholar 

  26. Matovina M, Sabol I, Grubisić G, Gasperov NM, Grce M (2009) Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions. Gynecol Oncol 113:120–127

    Article  PubMed  CAS  Google Scholar 

  27. Cheung JL, Lo KW, Cheung TH, Tang JW, Chan PK (2006) Viral load, E2 gene disruption status, and lineage of human papillomavirus type 16 infection in cervical neoplasia. J Infect Dis 194:1706–1712

    Article  PubMed  CAS  Google Scholar 

  28. Doeberitz V, Bauknecht M, Bartsch T, Zur Hauzen H (1991) Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc Natl Acad Sci USA 18:1411–1415

    Article  Google Scholar 

  29. Jeon S, Lambert PF (1995) Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci USA 92:1654–1658

    Article  PubMed  CAS  Google Scholar 

  30. Jeon S, Allen-Hoffmann B, Lambert P (1995) Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 69:2989–2997

    PubMed  CAS  Google Scholar 

  31. Boulet G, Horvath C, Vanden Broeck D, Sahebali S, Bogers J (2007) Human papillomavirus: E6 and E7 oncogenes. Int J Biochem Cell Biol 39:2006–2011

    Article  PubMed  CAS  Google Scholar 

  32. Storey A, Greenfield I, Banks L, Pim D, Crook T, Crawford L, Stanley M (1992) Lack of immortalizing activity of a human papillomavirus type 16 variant DNA with a mutation in the E2 gene isolated from normal human cervical keratinocytes. Oncogene 7:459–465

    PubMed  CAS  Google Scholar 

  33. Casas I, Powell L, Klapper PE, Cleator GM (1995) New method for the extraction of viral RNA and DNA from cerebrospinal fluid for use in the polymerase chain reaction assay. J Virol Methods 53:25–36

    Article  PubMed  CAS  Google Scholar 

  34. Puranen M, Saarikoski S, Syrjänen K, Syrjänen S (1996) Polymerase chain reaction amplification of human papillomavirus DNA from archival, Papanicolaou-stained cervical smears. Acta Cytol 40:391–395

    Article  PubMed  CAS  Google Scholar 

  35. Sotlar K, Diemer D, Dethleffs A, Hack Y et al (2004) Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol 42:3176–3184

    Article  PubMed  CAS  Google Scholar 

  36. Collins SI, Constandinou-Williams C, Wen K, Young LS, Roberts S, Murray PG, Woodman CB (2009) Disruption of the E2 gene is a common and early event in the natural history of cervical human papillomavirus infection: a longitudinal cohort study. Cancer Res 69:3828–3832

    Article  PubMed  CAS  Google Scholar 

  37. Kulmala SM, Syrjδnen SM, Gyllensten UB et al (2006) Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol 59:513–517

    Article  PubMed  CAS  Google Scholar 

  38. Peitsaro P, Johansson B, Syrjanen S (2002) Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 40:886–891

    Article  PubMed  CAS  Google Scholar 

  39. Gallo G, Bibbo M, Bagella L et al (2003) Study of viral integration of HPV-16 in young patients with LSIL. J Clin Pathol 56:532–536

    Article  PubMed  CAS  Google Scholar 

  40. Azizi N, Brazete J, Hankins C, Money D et al (2008) Canadian Women’s HIV Study Group. Influence of human papillomavirus type 16 (HPV-16) E2 polymorphism on quantification of HPV-16 episomal and integrated DNA in cervicovaginal lavages from women with cervical intraepithelial neoplasia. J Gen Virol 89:1716–1728

    Article  PubMed  CAS  Google Scholar 

  41. Giannoudis A, Duin M, Snijders PJ, Herrington CS (2001) Variation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix. Br J Cancer 84:1058–1063

    Article  PubMed  CAS  Google Scholar 

  42. Jiang M, Baseman JG, Koutsky LA, Feng Q, Mao C, Kiviat NB, Xi LF (2009) Sequence variation of human papillomavirus type 16 and measurement of viral integration by quantitative PCR. J Clin Microbiol 47:521–526

    Article  PubMed  CAS  Google Scholar 

  43. Graham DA, Herrington CS (2000) HPV-16 E2 gene disruption and sequence variation in CIN 3 lesions and invasive squamous cell carcinomas of the cervix: relation to numerical chromosome abnormalities. Mol Pathol 53:201–206

    Article  PubMed  CAS  Google Scholar 

  44. Eriksson A, Herron JR, Yamada T et al (1999) Human papillomavirus type 16 variant lineages characterised by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region. J Gen Virol 80:595–600

    PubMed  CAS  Google Scholar 

  45. Casas L, Galvan SC, Ordoñez RM, Lopez N, Guido M, Berumen J (1999) Asian-american variants of human papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas. Int J Cancer 83:449–455

    Article  PubMed  CAS  Google Scholar 

  46. Sathish N, Abraham P, Peedicayil A, Sridharan G, Shaji RV, Chandy G (2004) E2 sequence variations of HPV 16 among patients with cervical neoplasia seen in the Indian subcontinent. Gynecol Oncol 95:363–369

    Article  PubMed  CAS  Google Scholar 

  47. Watts KJ, Thompson CH, Cossart YE, Rose BR (2002) Sequence variation and physical state of human papillomavirus type 16 cervical cancer isolates from Australia and New Caledonia. Int J Cancer 97:868–874

    Article  PubMed  CAS  Google Scholar 

  48. Swan DC, Rajeevan M, Tortolero-Luna G, Follen M, Tucker RA, Unger ER (2005) Human papillomavirus type 16 E2 and E6/E7 variants. Gynecol Oncol 96:695–700

    Article  PubMed  CAS  Google Scholar 

  49. Meissner J (1997) Sequencing errors in reference HPV clones. In: Myers G, Munger K, Sverdrup F, McBride AA, Bernard HU, Meissner J (eds) Human Papillomavirus 1997: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, NM, pp 110–123

    Google Scholar 

  50. Veress G, Szarka K, Dong XP, Gergely L, Pfister H (1999) Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J Gen Virol 80:1035–1043

    PubMed  CAS  Google Scholar 

  51. Piccini A, Storey A, Massimi P, Banks L (1995) Mutations in the human papillomavirus type 16 E2 protein identify multiple regions of the protein involved in binding to E1. J Gen Virol 76:2909–2913

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by research grants of the Postgraduate Programme ‘Applications of Molecular Biology-Genetics. Diagnostic Biomarkers’, code 3817, of the University of Thessaly, School of Health Sciences, Department of Biochemistry & Biotechnology.

Conflict of interest

All authors declare that they have no conflicting or dual interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Markoulatos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsakogiannis, D., Ruether, I.G.A., Kyriakopoulou, Z. et al. Sequence variation analysis of the E2 gene of human papilloma virus type 16 in cervical lesions from women in Greece. Arch Virol 157, 825–832 (2012). https://doi.org/10.1007/s00705-012-1236-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00705-012-1236-8

Keywords

Navigation